PharmiWeb

BioInvent to Host Two Key Opinion Leader Events Highlighting Progress Across Oncology Portfolio

Events will feature expert perspectives on BI-1808 in ovarian cancer and T‑cell lymphomas, and BI-1206 for the treatment of NHL LUND, SE / ACCESS Newswire / April 29, 2026 / BioInvent International AB ...

BioInvent International: BioInvent to Host Two Key Opinion Leader Events Highlighting Progress Across Oncology Portfolio

Events will feature expert perspectives on BI-1808 in ovarian cancer and T-cell lymphomas, and BI-1206 for the treatment of NHL LUND, SE / ACCESS Newswire / April 29, 2026 / BioInvent International AB ...

Elicio Therapeutics: Hoping To Capitalize On Massive KRAS Hype, But Time Is Running Out

Elicio Therapeutics (ELTX) is approaching a pivotal trial readout for its KRAS peptide vaccine, positioning 2026 as a ...

European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted ...
Le Lézard

Frontier Scientific Solutions Appoints Michelle D'Angelo as Chief Commercial Officer

Frontier Scientific Solutions ("Frontier"), a leading provider of cGMP-compliant, temperature-controlled logistics solutions, today announced the appointment of Michelle D'Angelo as Chief Commercial ...